LCI 1461 (Dipyridamole 25 mg)
Pill imprint LCI 1461 has been identified as Dipyridamole 25 mg.
Dipyridamole is used in the treatment of prosthetic heart valves - thrombosis prophylaxis; radionuclide myocardial perfusion study and belongs to the drug classes cardiac stressing agents, platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Dipyridamole 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for LCI 1461 (Dipyridamole 25 mg)
- 25 mg
- Prescription only
- Drug Class:
- Cardiac stressing agents
Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Lannett Company, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
silicon dioxide colloidal
FD&C Red No. 40
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|10135-0536||Marlex Pharmaceuticals Inc|
Note: Inactive ingredients may vary.
Dipyridamole is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...